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determine the time to reach median and quartile survival (25%,
50% and 75%, respectively).
doi:10.1016/j.ejcsup.2010.06.073
O-73 SENTINEL NODE BIOPSY MAY BE MORE SENSITIVE FOR
DETECTING POSITIVE NODES THAN AXILLARY NODE SAMPLE:
RESULTS FROM A RETROSPECTIVE ANALYSIS
E.J. Macaskill a, K. Brauer b, C.A. Purdie c, D.C. Brown a.
aDepartment of Breast Surgery, Ninewells Hospital, Dundee,
UK. bDepartment of Breast Radiology, Ninewells Hospital, Dundee,
UK. cDepartment of Breast Pathology, Ninewells Hospital, Dundee,
UK
Background: While there have been a number of studies com-
paring axillary clearance with limited axillary surgery, there is lit-
tle data available comparing axillary sample (ANS) with sentinel
node biopsy (SNB). We report results of a retrospective audit of
ANS and SNB procedures performed in a single unit on two sites
over a 2 year period.
Results: In total 224 patients underwent limited axillary sur-
gery (ANS n = 142 (63%); SNB n = 82 (36%)) from January 2008 to
January 2010. Sentinel node biopsy was performed using a
combination technique with blue dye and radioisotope
injections.
The results shown in Table 1 show a significantly greater num-
ber of nodes taken with ANS compared with SNB. A significantly
higher proportion of patients having SNB had a positive node
(22% vs. 9.9%) despite similar baseline tumour characteristics
(tumour size, grade and NPI) in SNB and ANS groups, and a
greater number of positive nodes following ANC in the ANS
group.
These results suggest that SNB is more accurate at detecting
positive nodes even in low volume axillary disease. Data from
5 years (approx 500 patients) will be presented.
doi:10.1016/j.ejcsup.2010.06.074
O-74 HOW OFTEN DOES A POSITIVE SENTINEL LYMPH NODE
BIOPSY PROMPT AN ISOLATED DELAYED AXILLARY LYMPH
NODE DISSECTION?
J.R. Benson, G.C. Wishart, P. Forouhi, E. Provenzano. Cambridge
Breast Unit, Addenbrooke’s Hospital, Cambridge, UK
Methods for intra-operative node assessment can avoid
delayed axillary lymph node dissection (ALND) in a proportion
of sentinel lymph node biopsy (SLNB) patients. Both frozen sec-
tion and imprint cytology are inconsistent and of variable sensi-
tivity compared to paraffin embedded H&E sections and have
not yet been surpassed by molecular assays. Modern approaches
to axillary management can contribute to reduction in absolute
numbers of isolated completion ALND cases without intra-opera-
tive assessment.
A retrospective analysis was undertaken of 443 patients eligi-
ble for SLNB with clinically node negative tumours <5 cm.
Patients having SLNB before neoadjuvant therapy (27) or immedi-
ate breast reconstruction (IBR) (44) were excluded from further
analysis together with 15 patients undergoing single stage ALND
(level I/II) due to age or co-morbidity. Most of the remaining 357
patients had an axillary ultrasound examination (301/357) with
49 proceeding directly to ALND based on positive nodal core
biopsy (40), suspicious nodes with (6) or without (3) a negative
biopsy. Amongst 308 patients undergoing SLNB, 73 were node
positive (23%) and required completion ALND. Just over half these
had an isolated delayed ALND (40), whilst 33 patients had ALND
with an additional surgical procedure (re-excision, mastectomy
with or without IBR). The recall rate for delayed ALND alone
was <10% (40/443).
Intra-operative node assessment may be more difficult to jus-
tify for all SLNB patients in the context of contemporary surgical
practices which either deselect patients for SLNB or enable any
completion ALND to be performed as a component of definitive
breast surgery.
doi:10.1016/j.ejcsup.2010.06.075
O-75 FINE NEEDLE ASPIRATION CYTOLOGY IS A VALUABLE
ADJUNCT TO AXILLARY ULTRASOUND IN THE PREOPERATIVE
STAGING OF EARLY BREAST CANCER
Morna MacNeill, Isobel Arnott, Jeremy Thomas. Edinburgh Breast
Unit, Edinburgh, UK
Aims: To determine the predictive values of axillary fine needle
aspiration (FNA) cytology and ultrasound (US) and tumour size
and the influence of histological grade in the preoperative axillary
staging of early breast cancer.
Patients and methods: 314 patients:119 patients had suspicious
US investigated by FNA; 195 patients had normal US not investi-
gated further preoperatively. Review of case records and discrep-
ant cytology.
Results: Positive and negative predictive values (PPV & NPV) for
US status and tumour size (T stage are shown in Table 1. Of 195
patients with negative axillary US 37 (19%) had metastatic nodal
Table 1
ANS n = 142 SNB n = 82 p-Value
Median nodes
taken n (range)
4 (1–10) 2 (1–6) <0.0001
Positive node(s)
n of cases (%)
14 (9.9) 18 (22.0) 0.0226
Further positive nodes
on ANC n of cases (%)
4 (33.3) 4 (22.2) 0.0547
Total number of positive
nodes after ANC
mean (range)
2.7 (1–6) 1.3 (1–2) 0.0028
28 EJC SUPPLEMENTS 8 (2010) 1–36
disease. Fewer than 20% of these patients had micrometastases
alone. Tumour size and grade influenced node status in US-suspi-
cious cases only.
Conclusion: Axillary US has a moderately high PPV and NPV in
preoperative axillary staging. US gives false negative results in
20% of cases and only a small proportion of these can be
explained by micrometastases. Taking into account tumour size
improves the predictive value of the technique.
doi:10.1016/j.ejcsup.2010.06.076
O-76 BREAST RADIOTHERAPY FOR OCCULT BREAST CANCER
WITH AXILLARY NODAL METASTASES – DOES IT REDUCE
LOCAL RECURRENCE RATE AND INCREASE OVERALL SURVIVAL?
S. Masinghe, O. Faluyi, G. Kerr, I. Kunkler. Western General
Hospital, Edinburgh, UK
Background: The optimal management of axillary lymph node
metastases from occult breast cancer (TXN1-2M0) is uncertain
and practice varies in the use of primary breast radiotherapy.
We conducted a retrospective review to examine clinical out-
comes for patients managed with or without primary breast
radiotherapy.
Materials and methods: Case records from the Clinical Oncology
database were reviewed to identify patients presenting with axil-
lary nodal metastases but no detectable primary tumour for over
the period between 1974 and 2003. Fifty three patients with TXN1-
2M0 breast cancer were identified representing 0.4% of patients
managed for breast cancer during this period. Of those tested,
59% had oestrogen receptor positive tumours. 77% received ipsi-
lateral breast radiotherapy.
Results: There was a trend towards reduced ipsilateral breast
tumour recurrence in patients who received radiotherapy (16% at
5 years, 23% at 10 years) compared to those who did not (36% at
5 years, 52% at 10 years). Similarly, the locoregional recurrence rate
at 5 years was 28% for patients who received radiotherapy com-
paredto53.7%fornonirradiatedpatients.Breast cancer specificsur-
vival was higher (p = 0.0073; log-rank test) in patients who received
ipsilateral breast radiotherapy (72%at 5 years, 66%at 10 years) com-
pared to those who did not (58% at 5 years, 15% at 10 years).
Conclusion: Primary breast radiotherapy may reduce ipsilateral
breast tumour recurrence and increase survival inpatients present-
ing with axillary lymph nodemetastases and occult breast primary
(TXN1-2M0). Larger studies are needed to validate these findings.
doi:10.1016/j.ejcsup.2010.06.077
O-77 SENTINEL LYMPH NODE BIOPSY (SLNB) BEFORE PRIMARY
CHEMOTHERAPY (PC) IN BREAST CANCER PATIENTS
J.R. Benson, G.C. Wishart, G. Ambler, E. Provenzano. Cambridge
Breast Unit, Addenbrooke’s Hospital, Cambridge, UK
SLNB prior to PC will minimize risk of a false negative result
and allow more accurate initial staging which can guide treat-
ment decisions for adjuvant radiotherapy and axillary surgery.
A retrospective analysis was undertaken to examine upfront
SLNB amongst 46 patients with clinically node negative, non-
inflammatory invasive breast cancers measuring between 2 and
5 cm on initial imaging (irrespective of modality). Axillary ultra-
sound was performed in most patients (43/46), 10 of whom had
a negative core biopsy. Mean tumour diameter was 28.5 cm and
two patients had axillary lymph node dissection (ALND)
prompted by subsequent MRI size estimate (>5 cm). Dual localiza-
tion methods were employed and micrometastatic foci identified
on H&E sections; immunohistochemistry was not routinely
performed.
The sentinel node was identified in all patients with a mean of
2.7 nodes per patient (range 1–6). A total of 13 patients had posi-
tive nodes (28%) with 10 having involvement of a single node
(eight macrometastases; two micrometastases) and three
patients with two separate nodes, both containing a macrometas-
tasis (two patients) or each a macro- and micrometastasis (one
patient). The mean number of nodes removed on completion
ALND was 10.9 (range 7–32). Only one patient had tumour (micro-
metastasis) within a non-sentinel node (NSLN) and one other
patient had evidence of fibrosis suggesting tumour response to
PC.
A group of patients can be selected for SLNB before PC who
have a relatively low axillary tumour burden at presentation.
Potential downstaging with PC may result in a low incidence of
NSLN involvement with viable tumour.
doi:10.1016/j.ejcsup.2010.06.078
O-78 COMPARISON BETWEEN ENDOSCOPE-ASSISTED PARTIAL
MASTECTOMY WITH FILLING OF DEAD SPACE USING ABSORB-
ABLE MESH AND CONVENTIONAL CONSERVATIVE METHOD ON
COSMETIC OUTCOME IN PATIENTS WITH STAGES 1 AND 2
BREAST CANCER
Nobuyuki Takemoto a, Ai Koyanagi b. aDepartment of Breast and
Endocrine Surgery, Japan Medical Alliance Higashi Saitama General
Hospital, Japan. bDepartment of Global Health Policy, University of
Tokyo, Japan
Background and aims: Breast conservative therapy is currently
the mainstream of breast cancer treatment. There is increasing
interest in methods to further improve postoperative cosmesis
such as endoscopic surgery which was introduced in 1994 as an
alternative to Conventional Conservative Method (CCM). How-
ever, data on whether endoscopic surgery confers any additional
benefit to CCM in terms of cosmesis is lacking. We compared cos-
metic outcome between CCM and Endoscope-assisted Partial
Table 1
Variable PPV (%) NPV (%)
US suspicious vs. US negative – all cases 59 81
T1 vs. T2 – all cases 47 74
T2 cases – US suspicious vs. US negative 75 75
T1 cases – US suspicious vs. US negative 51 86
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